Detalhe da pesquisa
1.
Integrating Evidence to Guide Use of Biologics and Small Molecules for Inflammatory Bowel Diseases.
Gastroenterology
; 166(3): 396-408.e2, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37949249
2.
Defining Endoscopic Remission in Crohn's Disease: MM-SES-CD and SES-CD Thresholds Associated With Low Risk of Disease Progression.
Clin Gastroenterol Hepatol
; 2024 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38428709
3.
Resolution of rectal bleeding by day 7 in acute severe ulcerative colitis is prognostic for post-discharge corticosteroid free clinical remission and endoscopic improvement.
Am J Gastroenterol
; 2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38775974
4.
Delayed Ustekinumab and Adalimumab Responders Have Similar Outcomes as Early Responders in Biologic-Naïve Crohn's Disease.
Am J Gastroenterol
; 2024 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38235763
5.
Safety and Effectiveness of Vedolizumab in Elderly Patients with Inflammatory Bowel Disease: A Systematic Review & Meta-Analysis.
J Clin Gastroenterol
; 58(4): 378-388, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37224287
6.
Prognostic Value of Fecal Calprotectin to Inform Treat-to-Target Monitoring in Ulcerative Colitis.
Clin Gastroenterol Hepatol
; 21(2): 456-466.e7, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35934286
7.
Predictors of Placebo Induction Response and Remission in Ulcerative Colitis.
Clin Gastroenterol Hepatol
; 21(4): 1050-1060.e9, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36029969
8.
Delayed Ustekinumab Responders in Ulcerative Colitis Have Greater Inflammatory Burden but Similar Outcomes as Early Responders.
Clin Gastroenterol Hepatol
; 21(13): 3387-3396.e1, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37391059
9.
Comparative Safety and Effectiveness of Biologic Therapy for Crohn's Disease: A CA-IBD Cohort Study.
Clin Gastroenterol Hepatol
; 21(9): 2359-2369.e5, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36343846
10.
Effectiveness and Safety of Biologic Therapy in Hispanic Vs Non-Hispanic Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study.
Clin Gastroenterol Hepatol
; 21(1): 173-181.e5, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35644340
11.
Long-Term Outcomes of Early vs Delayed Responders to Vedolizumab and Adalimumab: A Post Hoc Analysis of the VARSITY Study.
Am J Gastroenterol
; 118(1): 121-128, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36066459
12.
Role of hyperbaric oxygen therapy in patients with inflammatory bowel disease.
Curr Opin Gastroenterol
; 39(4): 263-267, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37265170
13.
Baseline Patient-reported Symptoms Less Predictive Than MM-SES-CD for Endoscopic Remission in Crohn's Disease.
J Clin Gastroenterol
; 57(9): 913-919, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36227009
14.
End of induction patient reported outcomes predict clinical remission and endoscopic improvement with vedolizumab and adalimumab in ulcerative colitis.
Scand J Gastroenterol
; 58(1): 7-14, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35909369
15.
Vedolizumab and Adalimumab in Biologic-Naïve Ulcerative Colitis: Comparison of Patient-Level Clinical Trial Data and VARSITY for Week 6 Clinical Remission.
Dig Dis Sci
; 68(6): 2658-2666, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36645636
16.
Comparative Efficacy of Infliximab Versus Tofacitinib for Inducing Remission in Biologic Naive Ulcerative Colitis: A Propensity Matched Study.
Dig Dis Sci
; 68(6): 2635-2646, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37119375
17.
Correlations Between Gastrointestinal Symptoms and Endoscopic-Histologic Disease Activity in Adults with Ulcerative Colitis.
Dig Dis Sci
; 68(8): 3254-3258, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37268795
18.
Predicting endoscopic remission in Crohn's disease by the modified multiplier SES-CD (MM-SES-CD).
Gut
; 71(6): 1078-1087, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33766910
19.
Effectiveness of Reinduction and/or Dose Escalation of Ustekinumab in Crohn's Disease: A Systematic Review and Meta-analysis.
Clin Gastroenterol Hepatol
; 20(12): 2728-2740.e1, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34628078
20.
Clinical Decision Support Tool for Infliximab in Crohn's Disease.
Clin Gastroenterol Hepatol
; 20(5): e1192-e1195, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34216825